Color Doppler Imaging of Ocular Blood Flow after Combined Photodynamic Therapy with Intravitreal Triamcinolone in Age-Related Macular Degeneration

REFERENCES

• VanNewkirk MR, Nanjan MB, Wang JJ, et al. The prevalence of age-related maculopathy: The visual impairment project. Ophthalmology. 2000;107:1593–1600.
   PubMed Web of Science ®Google Scholar
• Miller J, Schmidt-Erfurth U, Sickenberg M, et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol. 1999;117:1161–1173.
   PubMedGoogle Scholar
• Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin one-year results of 2 randomized clinical trials. TAP Report 1. Arch Ophthalmol. 1999;117:1329–1345.
   PubMed Web of Science ®Google Scholar
• Bressler NM. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: Two-year results of 2 randomized clinical trials. TAP Report 2. Arch Ophthalmol. 2001;119:198–207.
   PubMed Web of Science ®Google Scholar
• Frimpong-Boateng A, Bunse A, Rüfer F, et al. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: Functional results in 54 patients. Acta Ophthalmol. 2009;87:183–187.
   PubMedGoogle Scholar
• Türkçüoğlu P, Deniz N, Koç M, et al. The effect of photodynamic therapy on retrobulbar blood flow parameters. Clin Exp Ophthalmol. 2008;36:39–42.
   Google Scholar
• Maar N, Pemp B, Kircher K, et al. Ocular haemodynamic changes after single treatment with photodynamic therapy assessed with non-invasive techniques. Acta Ophthalmol. 2009;87:631–637.
   PubMedGoogle Scholar
• Vinh Moreau-Gaudry V, Geiser M, Romanet JP, et al. Effects of photodynamic therapy on subfoveal blood flow in neovascular age-related macular patients. Eye. 2010;24:706–712.
   PubMed Web of Science ®Google Scholar
• Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367–374.
   PubMed Web of Science ®Google Scholar
• Barbazetto I, Burdan A, Bressler NM, et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: Fluorescein angiographic guidelines for evaluation and treatment—TAP and VIP Report 2. Arch Ophthalmol. 2003;121:1253–1268.
   PubMedGoogle Scholar
• Friedman E, Krupsky S, Lane AM, et al. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology. 1995;102:640–646.
   PubMed Web of Science ®Google Scholar
• Grunwald J, Hariprasad, S, DuPont J, et al. Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1998;39:385–390.
   PubMed Web of Science ®Google Scholar
• Ciulla TA, Harris A, Chung HS, et al. Color Doppler imaging discloses reduced ocular blood flow velocities in non-exudative age-related macular degeneration. Am J Ophthalmol. 1999;128:75–80.
   PubMed Web of Science ®Google Scholar
• Ciulla TA, Harris A, Kagemann L, et al. Choroidal perfusion perturbations in non-neovascular age-related macular degeneration. Br J Ophthalmol. 2002;86:209–213.
   PubMed Web of Science ®Google Scholar
• Harris A, Chung H, Ciulla T, et al. Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration. Prog Retinal Eye Res. 1999;18:669–687.
   PubMedGoogle Scholar
• Fingar V, Wieman T, Wiehle S, et al. The role of microvascular damage in photodynamic therapy: The effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 1992;52:4914–4921.
   PubMed Web of Science ®Google Scholar
• Çekiç O, Keserci B, Ohji M, et al. Macular translocation surgery and retinal circulation times. Retina. 2004;24:51–56.
   Google Scholar
• Çekiç O, Keserci B, Ohji M, et al. Evaluation of choroidal perfusion of the new central macular area by dilution analysis of indocyanine green angiography after macular translocation. Retina. 2004;24:210–214.
   Google Scholar
• Ciulla TA, Harris A, Kageman L, et al. Transpupillary thermotherapy for subfoveal occult choroidal neovascularization: Effect on ocular perfusion. Invest Ophthalmol Vis Sci. 2001;42:3337–3340.
   Google Scholar
• Tsai CC, Kau HC, Tsai HH, et al. Pulsatile ocular blood flow change after treatment with systemic steroid in patients with Grave’s ophthalmopathy. Eye. 2006;20:1025–1029.
   Google Scholar
• Çekiç O, Bardak Y, Tiğ SU, et al. Hemodynamic response to intravitreal triamcinolone in eyes with macular edema: Intravitreal triamcinolone and ocular blood flow. Int Ophthalmol. 2007;27:313–319.
   PubMedGoogle Scholar
• Mawatari Y, Koga T, Inumaru J, et al. The effect of subtenon triamcinolone acetonide injection for diabetic macular edema on retinal and choroidal circulation. Am J Ophthalmol. 2005;140:948–949.
   PubMed Web of Science ®Google Scholar
• Mete A, Saygili O, Mete A, et al. Effects of intavitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration. J Clin Ultrasound. 2010;38:66–70.
   PubMed Web of Science ®Google Scholar
• Dimitrova G, Kato S. Color Doppler imaging of retinal diseases. Survey Ophthalmol. 2010;55:193–214.
   PubMed Web of Science ®Google Scholar
• Bardak Y, Çekiç O, Arslanyıldız A, et al. Effects of photodynamic treatment on ocular perfusion and macular functions. ARVO Meeting, Fort Lauderdale, Florida, April 30-May 4, 2006; Invest. Ophthalmol. Vis. Sci., 47(4): Abstract no. 342.
   Google Scholar